Clinical Trials on Neuroendocrine Tumors, NET in New Zealand
Total 3447 results
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)RecruitingNeuroblastoma | PheochromocytomaUnited States
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; Weill Medical College of Cornell UniversityActive, not recruiting
-
Adil DaudNational Comprehensive Cancer NetworkCompleted
-
Provectus PharmaceuticalsCompleted
-
QBiotics Group LimitedMerck Sharp & Dohme LLCTerminated
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCNot yet recruitingMucosal MelanomaAustralia
-
Memorial Sloan Kettering Cancer CenterPfizerRecruiting
-
Yale UniversityTerminatedMetastatic MelanomaUnited States
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
Prof. Dr. med. Dirk SchadendorfBristol-Myers SquibbActive, not recruitingMerkel Cell CarcinomaGermany, Netherlands
-
Melanoma Institute AustraliaNovartisRecruiting
-
Ludwig Institute for Cancer ResearchBristol-Myers Squibb; Conquer Cancer FoundationCompleted
-
Bristol-Myers SquibbCompleted
-
Ryan StephensonRecruiting
-
Dartmouth-Hitchcock Medical CenterTerminated
-
Yale UniversityNovartisTerminatedMetastatic MelanomaUnited States
-
Columbia UniversityMerck Sharp & Dohme LLCTerminated
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Memorial Sloan Kettering Cancer CenterYale University; University of New MexicoCompleted
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLC; NovartisActive, not recruiting
-
Northwestern UniversityDartmouth-Hitchcock Medical Center; Loyola UniversityCompleted
-
QBiotics Group LimitedTerminated
-
Molecular Insight Pharmaceuticals, Inc.CompletedPheochromocytoma | ParagangliomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
NYU Langone HealthBristol-Myers Squibb; Daiichi Sankyo, Inc.CompletedMelanomaUnited States
-
Ichor Medical Systems IncorporatedMemorial Sloan Kettering Cancer CenterCompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, Taiwan, Australia
-
Novartis PharmaceuticalsCompleted
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Novartis PharmaceuticalsTerminated
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbTerminatedMelanomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Hackensack Meridian HealthNational Cancer Institute (NCI)WithdrawnMelanoma (Skin)United States
-
NYU Langone HealthActive, not recruiting
-
Bristol-Myers SquibbRoche-GenentechTerminated
-
Memorial Sloan Kettering Cancer CenterCompletedMelanoma | Survivors | Psychological FactorsUnited States
-
Esanex Inc.Completed
-
AdaptimmuneTerminated
-
PfizerCompleted
-
BioVex LimitedSymbion Research InternationalCompletedMelanomaUnited Kingdom, United States
-
Anthony Joshua, FRACPSt Vincent's Hospital, SydneyActive, not recruiting
-
Melanoma Institute AustraliaMerck Sharp & Dohme LLCActive, not recruitingMelanoma Stage IIIAustralia
-
Yale UniversityCompleted
-
Bristol-Myers SquibbCompleted